Our results confirmed that GZMB + CD8 + T cells markedly increased in tumor tissues following the addition of a PD-L1 inhibitor, and immunostaining of tumor sections also displayed enhanced caspase-3 expression. This evidence concerns the gene CD8A and neoplasm.